SOX2 and lung carcinoma: demonstrated that SOX2 promoted SLC7A11 transcription by binding to SLC7A11 promoter, and oxidation at Cys265 of SOX2 inhibited its activity and decreased the self-renewal capacity of lung cancer stem cell-like cells.